Enlibrium Finds $15M For Cancer Drugs
socalTECH
DECEMBER 4, 2015
The funding was led by Avalon Ventures and TPG Biotech, and also included Correlation Ventures and Osage University Partners. The startup said it is developing novel drugs based on the anti-cancer activity of metformin and designed to reduce cancer energy production to treat a range of cancer types. The company was founded by Dr.
Let's personalize your content